Precigen (PGEN)
Commercializes PAPZIMEOS while developing selected gene and cell therapies.
$7.49
vs last close−0.40 (−5.07%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 39.13% | 140.10M shares | |
|---|---|---|---|
| 225 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 39.95% | 143.05M shares | |
| 12 holders · as of Aug 28, 2026 | |||
| Strategic holders | 9.51% | 34.05M shares | |
| 1 holder · as of Sep 23, 2025 | |||
| Other | ≈ 11.41% | 40.84M shares | |
| remainder | |||
358.04M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
225 holders · 140.10M shares · 40 new positions · 126 increased · 46 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Patient Capital Management, LLC | 19.04M | 5.32% | +1.22M | Aug 13, 2026 |
| BlackRock, Inc. | 17.15M | 4.79% | +1.92M | Aug 7, 2026 |
| State Street Corp | 12.00M | 3.35% | +1.11M | Aug 7, 2026 |
| Diametric Capital, LP | 9.27M | 2.59% | +2.47M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.91M | 2.21% | +757.2K | Aug 13, 2026 |
| Tang Capital Management LLC | 6.42M | 1.79% | 0 | Aug 14, 2026 |
| Boxer Capital Management, LLC | 5.15M | 1.44% | +1.65M | Aug 14, 2026 |
| Geode Capital Management, LLC | 5.02M | 1.40% | +405.6K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Randal J. Kirkincl. Third Security, LLC, R.J. Kirk Declaration of Trust | 35.90% | 133.96M | 13D | Mar 31, 2026 |
| Patient Capital Management, LLC | 10.20% | 36.01M | 13G | Feb 13, 2026 |
| William H. Miller III Living Trust dated April 17, 2017 | 9.20% | 34.05M | 13G | Sep 23, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jeffrey B. Kindlerdirector | Sale | 185,000 | $7.44 | 17,100 |
| Aug 21, 2026 | Nancy H. Ageedirector | Purchase | 3,411 | $7.23 | 309,187 |
| Aug 25, 2026 | Phil Tennantofficer: Chief Commercial Officer | Sale | 79,166 | $7.50 | 141,992 |
| Aug 25, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 15,342 | $7.50 | 468,865 |
| Aug 21, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 34,658 | $7.50 | 465,012 |
| Aug 6, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 32,739 | $6.86 | 465,012 |
| Aug 3, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 33,772 | $6.50 | 497,751 |
| Jul 31, 2026 | Harry Jr. Thomasianofficer: Chief Financial Officer | Sale | 100,000 | $6.06 | 254,535 |
| Jun 29, 2026 | Helen Sabzevariofficer: President and CEO | Sale | 346,836 | $5.89 | 3,768,872 |
| Jun 29, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 42,924 | $5.85 | 497,751 |
House and Senate disclosures
Not reported.